Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
Staff Only
| Advisory Board |
|
Stuart Altman, PhD Kathleen Buto, MPA Donald E. Casey Jr., MD, MPH, MBA, FACP Robert W. Dubois, MD, PhD Roberta Herman, MD George Isham, MD, MS David Lansky, PhD Keith D. Lillemoe, MD Robert McDonough, MD Newell McElwee, PharmD, MSPH Dolores Mitchell Joshua Ofman, MD, MSHS Rita Redberg, MD, MSc, FACC Murray Ross, PhD Lewis Sandy, MD Eric Silfen, MD, MSHA Andrea Sutcliffe, BA (Hons) Brian Sweet, BS Pharm, MBA Bill Thorwarth, MD Reed Tuckson, MD Gail Wilensky, PhD Patient Advocacy Organization - TBN |
Ongoing Appraisals
Recently Completed Appraisals
Other Key ICER Publications
- Management Options for Low Back Disorders: Final Appraisal
- IMRT for Localized Prostate Cancer: Final Appraisal
- Computed Tomography Colonography and Conventional Colonoscopy: Final Appraisal
- Brachytherapy and Proton Beam Therapy for Clinically Localized, Low-Risk Prostate Cancer: Final Appraisal
- Coronary Computed Tomographic Angiography and Invasive Coronary Angiography: Final Appraisal